Abstract. The occurrence of renal abnormalities was investigated in patients with onchocerciasis in comparison to individuals without onchocerciasis in Guinea. Serum creatinine levels, excretion of urinary marker proteins, and kidney size by ultrasound were determined. A high prevalence of glomerular as well as tubular dysfunctions was observed; however, no association with onchocerciasis could be detected. We also hypothesized that patients with hyperreactive onchocerciasis might be prone to develop immune-mediated glomerular disorders; however, this could not be verified. Following treatment with ivermectin, a slight but significant increase in the excretion of urinary albumin and ␣1-microglobulin was seen five days after treatment in all treated patients, whereas levels of proteinuria were significantly higher five days after treatment only in patients with high microfilarial densities. Our results indicate that ivermectin can cause glomerular and tubular disturbances in patients with onchocerciasis; however, these are minor and do not seem to be clinically relevant.
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Onchocerciasis or river blindness is caused by the filaria Onchocerca volvulus and expresses predominantly dermatologic and ocular manifestations. Migrating microfilariae (mf) are found in the skin and eyes, less frequently in the lymph nodes, and occasionally in internal organs and urine.
In tropical regions, a high incidence of renal dysfunction is documented. In the older literature, rare case reports about glomerulonephritis in patients with lymphatic filariasis have been published. [1] [2] [3] [4] [5] [6] In patients with glomerulonephritis, Wuchereria bancrofti or Brugia malayi infections were occasionally found. 7 In a study from India, 14 of 94 patients with Bancroftian filariasis who had proteinuria, hematuria, or chyluria and underwent renal biopsy showed predominantly mesangioproliferative changes and tubular degeneration in several cases. 8 In a hospital-based study of 20 asymptomatic microfilaremic patients and five symptomatic patients with W. bancrofti infections, Dreyer and others 9 found a slightly elevated proteinuria in 20% and hematuria in 35% of the microfilaremic patients. In another study, B. malayiinfected patients exhibited significantly increased proteinuria compared with (although younger) controls, and quantitative urine analyses suggested predominantly tubular disorders in asymptomatic infections, glomerular and tubular involvement in the course of filarial fever, and severe, predominantly glomerular disease in symptomatic cases. 10 The specific mechanisms underlying these renal abnormalities have not been defined, but mechanical damage to the glomeruli by mf and immunologic damage by immune complexes have been suggested. 10 There are also sporadic reports of renal involvement in loiasis. 11 A cross-sectional study of onchocerciasis in Cameroon showed a higher prevalence of proteinuria in subjects from an area with onchocerciasis compared with controls from an area designated as relatively free of onchocerciasis. 12 To date, there is no conclusive evidence for renal disorders in onchocerciasis.
It has been reported that a course of diethylcarbamazine (DEC) or ivermectin can induce transient proteinuria and hematuria in patients with lymphatic filariasis 9 and in loiasis. 13, 14 In the previously mentioned study by Dreyer and others, 9 transient proteinuria or hematuria was induced by treatment with DEC in nine of the 11 patients with normal findings before treatment. Studies of renal abnormalities following treatment with ivermectin in patients with onchocerciasis have not been published.
The objectives of our study were to investigate the occurrence of renal abnormalities in patients with onchocerciasis. The study design included three parts: A) a population-based, cross-sectional investigation in patients with and without onchocerciasis in a mesoendemic village in Guinea, B) a hospital-based, cross-sectional investigation in patients with generalized or hyperreactive onchocerciasis and in putative immune individuals in hyperendemic villages, and C) a cohort study of patients with onchocerciasis treated with ivermectin.
SUBJECTS AND METHODS
The occurrence of renal abnormalities was investigated in a population-based study in a mesoendemic village (part A), in a study composed of patients with a generalized or a hyperreactive form of onchocerciasis and putative immune individuals residing in a hyperendemic area (part B), and in cohort study of patients treated with ivermectin (part C).
Study population. The study was performed from January to March 1997 in the Research Unit of the Bernhard Nocht Institute in the forest area around Macenta (Republic of Guinea). The study protocol was reviewed and approved by the Ethics Committee of the Ministre de la Santé (Conakry, Guinea). Procedures and methods of examination were explained to the participants in the local language, and informed consent was obtained from all adult participants and from parents or legal guardians of minors. In addition, village representatives and local health authorities were informed and provided their consent.
Survey. Persons more than 12 years old who agreed to participate were included in the initial examination. All participants underwent clinical examination for signs of onchocerciasis such as skin lesions and subcutaneous nodules. For the evaluation of the mf carrier rate, two skin snips were taken from the buttocks. Oral Mazzotti tests with 50 mg of DEC were performed in patients from hyperendemic villages with negative skin snips to identify putatively immune individuals. A negative Mazzotti reaction was defined as the failure to develop pruritus during the next 24 hr and by two additional negative skin test results after 24 hr. A survey on the prevalence of W. bancrofti was done in cooperation with the General Hospital in Macenta. No mf were seen in blood samples of 50 patients taken at night. Thus, it was concluded that only onchocerciasis but no other filarial infections existed in the study subjects. Mass treatment campaigns with ivermectin had not been previously performed in this area.
Part A. Population-based, cross-sectional study in patients with and without onchocerciasis. This study was performed in Bourounou, a mesoendemic village 4 km south of Macenta (8Њ32ЈN, 90Њ29ЈW). The villagers are mostly ethnic Malinke. Eighty-three adults, which represented the majority of the population, participated in the initial survey. Onchocerciasis was defined by a positive skin snip or a palpable nodule containing adult worms detected by nodulectomy. Patients without onchocerciasis were defined by negative skin snips and the absence of palpable nodules. In addition, 22 villagers with a clear-cut IgG4 serum antibody response to O. volvulus extract were excluded because it was hypothesized that these individuals were infected but had microfilaria counts below the detection level. [15] [16] [17] Part B. Cross-sectional investigation in patients with generalized onchocerciasis and hyperreactive onchocerciasis and in putative immune individuals. Surveys were conducted from 1995 to 1997 in 14 villages hyperendemic for onchocerciasis. A total of 2,945 persons were examined. The mean community microfilarial load 18 in these villages was 2.8 mf/ mg of skin (range ϭ 0.9-12.2 mf/mg). All patients who underwent nodulectomy from January to March 1997, all patients detected with hyperreactive onchocerciasis, and all patients found to be putative immune individuals were included in this part of the study. A chronic hyperreactive form of onchocerciasis was characterized by a localized dermatitis and Ͻ 3 mf/mg of skin. In this group, one patient was included who had a typical localized dermatitis but no detectable mf in six skin snips, but high isotype responses to O. volvulus antigen extract (IgG1 Ͼ 10,000 U/ml, IgG3 Ͼ 10,000 U/ml). 19 Putative immune individuals were defined as persons living in hyperendemic villages for more than 12 years who had no palpable nodules or signs of dermatitis, had no mf in six skin snips taken at different sites, had no prior treatment with DEC or ivermectin, and failed to show a positive Mazzotti reaction, but had a positive IgG1 serum antibody response to O. volvulus extract, indicating exposure to the parasite. 17, 19 Part C. Cohort study of patients with onchocerciasis treated with ivermectin. Thirty patients with onchocerciasis from Bourounou and 16 patients with high microfilarial densities (Ͼ 80 mf/mg) from other villages were treated with a single dose of ivermectin (Ͻ 150 g/kg) and followed for five days without observing side effects. Females were examined for pregnancy by ultrasound, and pregnant women were excluded.
Clinical and technical examinations. All patients in one of the three parts of the study were re-examined clinically; this included the measurement of blood pressure. An ultrasound examination of the kidney was performed using portable ultrasonic equipment (Echo View SDU 350; Shimadzu, Kyoto, Japan) with a convex 3.75 MHz transducer and a microconvex 3.5 MHz transducer. The volume of the kidney and of its central echogenic area was calculated by the formula volume ϭ length ϫ width ϫ thickness ϫ 0.5.
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Blood analyses. Blood glucose levels were determined by the Haemo-Glucotest (Boehringer Mannheim, Mannheim, Germany). Serum was kept at Ϫ20ЊC and transported to Germany. Serum creatinine levels were determined by a photometric system with the enzyme creatinine aminohydrolase using a Vitros 250 analyzer (Johnson and Johnson Clinical Diagnostics, Neckargmünd, Germany). Total serum protein was determined by the biuret method using the same analyzer. Total serum IgE was measured by nephelometry using anti-human IgE-coated polystyrene latex particles (Behringwerke, Frankfurt, Germany). Serum electrophoresis was done on agarose gels using electrophoresis chambers (Hydrasys; Sebia GmbH, Fulda, Germany). Thick blood films were prepared to detect Plasmodium infections. Intestinal nematode and Schistosoma mansoni infections were detected by examination of fecal samples using an acid-ether sedimentation method (Telemann technique). A serologic test for quartan malaria was performed using an indirect fluorescence antibody test with heterologous antigen from Plasmodium brazilianum. 21 Serum specimens from all patients were tested for hepatitis B virus surface antigen using kits obtained from Abbott Laboratories (Abbott Park, IL). For hemoglobin electrophoresis, erythrocytes were washed three times in saline and frozen. Electrophoresis then was performed in Germany using electrophoresis chambers. The electrophoresis gels were evaluated using a densitometer (Multiphorese System IV-Densitometer; Vogel Medizinische Technik und Elektronik GmbH, Gieben, Germany).
Urine analyses. Samples of spontaneously released morning urine were collected in polystyrene tubes. Semi-quantitative urine analysis was performed with multi-test urine reagent strips (Combur 9 Test; Boehringer Mannheim). The test strips indicate erythrocyturia (Ͼ 5 cells/ml), leukocyturia (Ͼ 10 cells/ml), nitrite, pH, proteinuria (Ͼ 6 mg of albumin/ dl), glucose (Ͼ 40 mg/dl), ketone bodies (Ͼ 5 mg of acetacidic acid or Ͼ 40-70 mg of acetone/dl), and urobilinogen (Ͼ 0.4 mg/dl). Creatinine in urine samples was detected with the enzyme creatinine aminohydrolase using a Vitros 250 analyzer. Protein in urine was detected using a modified Bradford method (Bio-Rad Laboratories, Munich, Germany). The protein content was related to the creatinine content of the samples to warrant the comparability of the results. Albumin concentrations were determined turbidimetrically using anti-human albumin (Behringwerke) measured with a nephelometer (Nephelometer 100, Behringwerke). Detection of ␣1-microglobulin and transferrin were performed using immunologic reactions in which the substances in the urine samples form immune complexes with specific antibodies (Behringwerke) and measured with the same nephelometer.
Reference values were taken from Caucasian populations in the literature because no normal values for African populations are available: 22 urine protein Յ 7 mg/dl, albumin Յ 2 mg/dl, IgG Յ 1 mg/dl, transferrin Յ 0.25 mg/dl, and ␣1-microglobulin Յ 1.2 mg/dl. Total protein also was related to creatinine; 70 mg/g of creatinine was considered the upper normal limit. 23 Classification of proteinurias was done as shown in Table 1 . A high correlation was found between albumin and IgG in urine (r ϭ 0.97) and between albumin and transferrin in urine (r ϭ 0.63), whereas albuminuria was not correlated with tubular dysfunction measured by excretion of ␣1-microglobulin (r ϭ 0.14).
In participants of part A of the study, urine passed at noon was microscopically examined once using the Nucleopore filter method (Nucleopore Corp., Pleasanton, CA) for S. haematobium. In participants of part B of the study, 100 ml of urine were centrifuged and the sediments were checked for Schistosoma eggs.
Determination of IgG isotypic antibody to O. volvulus antigen. Analysis of IgG was performed using a modified ELISA as described. 19 The IgG isotype activity was calculated by use of the titration-curve method in arbitrary units representing the titer of a positive reaction (greater than the cut-off level) determined by linear regression.
Statistical analysis. For individual measurements below the detectability threshold of the test (albumin in urine ϭ 0.910 mg/dl, IgG in urine ϭ 0.300 mg/dl, ␣1-microglobulin ϭ 0.500 mg/dl, transferrin ϭ 0.210 mg/dl), half of this value was taken for calculation. Results are expressed as mean Ϯ SD for normally distributed data and median and 25% ϩ 75% percentiles for skewed data. The Student's paired or unpaired t-tests for normally distributed data and the MannWhitney U test for skewed data were used to evaluate the difference between mean values. Significant differences in the prevalences of the various types of proteinurias were assessed by Fisher's exact test and the clump test using a Monte Carlo approach. Significant differences in the prevalences of concomitant diseases were excluded by Fisher's exact test. Differences in the immunoglobulins and urine parameters between the study groups were analyzed using the Kruskal-Wallis test in combination with the U test.
RESULTS
Part A. Population-based, cross-sectional study in patients with and without onchocerciasis. The crude prevalence of mf carriers in the mesoendemic village was 40%. The community microfilarial load in the village was 0.39 mf/mg of skin. Thirty-two patients were diagnosed as having generalized onchocerciasis; 19 of them were skin snip positive and 17 had onchocercomata. The number of mf and values for isotype-specific antigen responses are shown in Table 2 . The study groups with and without onchocerciasis were comparable concerning age, sex, and prevalence of other diseases.
The results of the renal function tests are shown in Table  3 . No differences were detected between patients with and without onchocerciasis concerning renal function and ultrasound findings. Semi-quantitative urine analysis performed with multi-test urine reagent strips also did not reveal significant differences between the groups. Elevated urinary protein concentrations Ͼ 70 mg/g of creatinine in spontaneously voided urine were encountered in 47% of the patients with onchocerciasis and in 63% of the patients without onchocerciasis. Glomerular, tubular, and glomerular-tubular proteinurias were similarly detected in patients with and without onchocerciasis (Figure 1 ). Four patients with onchocerciasis and two patients without onchocerciasis had renal cysts, and one patient without onchocerciasis a large vesical calculus.
Part B. Cross-sectional investigation in patients with generalized and hyperreactive onchocerciasis and in putative immune individuals. Seventy patients with a generalized form of onchocerciasis undergoing nodulectomy, nine patients with a hyperreactive form, and 16 putative immune individuals were included in this part of the study. Patients with hyperreactive onchocerciasis were predominantly females and younger than patients with generalized onchocerciasis, and putative immune individuals were also younger than patients with generalized onchocerciasis. Therefore, for comparison of the results subgroups of only female patients with generalized onchocerciasis, as well as male and female patients Ͻ 25 years old with generalized onchocerciasis, were analyzed separately.
No significant differences in renal function were found between patients with different forms of onchocerciasis and the putative immune individuals. The results of the multitest urine reagent strips were also similar in the different groups. The prevalence of nonselective glomerular proteinuria was significantly higher in those with the hyperreactive form of onchocerciasis and in putative immune individuals than in those with the generalized form (P Ͻ 0.01, by Fisher's exact test), whereas other forms of proteinuria were slightly more frequent in those with generalized disease (Figure 2) . Part C. Cohort study of patients treated with ivermectin. In 46 patients with onchocerciasis treated with a single dose of ivermectin, a slight but significant increase (P Ͻ 0.01, by sign test) of excreted total urine protein (related to creatinine) was found after 48 hr and five days in comparison with pretreatment levels (Figure 3 ). When the 16 patients with high microfilarial densities (Ͼ 80 mf/mg) were considered separately, levels of proteinuria five days after treatment were also significantly higher than pretreatment levels (P Ͻ 0.01 by sign test) (Figure 4 ). Albumin and ␣1-microglobulin levels were slightly elevated after five days FIGURE 3. Excretion of different urinary proteins in patients with generalized onchocerciasis before and after treatment with ivermectin. The box plots show the 25th, 50th, and 75th percentiles, and the whiskers represent the Ͻ 25th to 10th and Ͼ 75th to 90th percentiles, respectively. ( Figure 3) , whereas IgG and transferrin levels were unchanged.
DISCUSSION
Reliable statistics on the epidemiology of various types of glomerulopathies in tropical countries are not available, but the incidence is much greater in the tropics than in temperate regions. 24, 25 One reason might be that numerous infectious diseases, among them several parasitic infections, have been shown to be associated with glomerular disease, although the exact pathogenic mechanisms have not been elucidated. 26 Clinical and epidemiologic studies have established the existence of renal disease associated with lymphatic filariasis, but not with onchocerciasis. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] We have examined renal function in patients with onchocerciasis. Renal function was assessed by measuring serum creatinine and several marker proteins in the urine. Measurement of total urinary protein was related to urinary creatinine because these ratios have been shown to have a high correlation with timed 24-hr urinary protein excretions. 27 Obtaining a random urine samples is easier than obtaining 24-hr urine samples in tropical countries, and this method also avoids errors when urine samples are lost, contaminated, or mixed with stool. A qualitative analysis of urine proteins was used to discriminate glomerular disorders from tubular ones.
The basement membrane of the glomerula, which serves as a barrier for high molecular weight proteins, is altered in all forms of glomerulopathy, and the typical excretion pattern is characterized by an increase in albumin. Immunoglobulin G has a molecular mass more than twice that of albumin and elevated urinary levels of IgG indicate a more severe glomerular involvement. Transferrin has been described as another sensitive marker for glomerular dysfunction. 28, 29 Urinary excretion of ␣1-microglobulin has been shown to reflect defects in tubular reabsorption in acute and chronic tubulo-interstitial diseases. 30, 31 In progressive renal diseases, dysfunction of glomerular filtration and tubular reabsorption are found together, giving rise to so-called tubuloglomerular proteinuria. In addition, we have analyzed urine samples for the presence of leukocytes, erythrocytes, and nitrite to detect urinary infection.
In our study, a high prevalence of glomerular as well as tubular dysfunctions was detected; however, no association with onchocerciasis could be detected. In our groups, albuminuria was present in 24.4% and elevated IgG levels in the urine were found in 20.6% of the subjects. When urinary protein excretion of 70 mg/g of creatinine was taken as the upper normal limit, 23 61% of the study participants had an elevated urinary protein excretion. However, these high values were due to low urine creatinine levels, the reason for which is unknown. Urinary transferrin excretion was ele-vated in only 4% of the patients and seems to be less sensitive for early detection of glomerular dysfunction in our populations.
There is no explanation for the high prevalence of renal dysfunction in our study, but the prevalence is comparable with prevalences from other tropical countries. 24, 25 To guarantee comparability of the groups with and without onchocerciasis, we examined our patients for hypertension and diabetes mellitus, but also for other infections associated with glomerular or tubular dysfunction: quartan malaria, schistosomiasis, and hepatitis B. 26 However, no association of renal dysfunction with these infections could be found. Renal complications can also occur in patients with the sickle cell trait, e.g., hematuria and proteinuria have been described, 32 and with regard to tubular function, hyposthenuria occurs in a high proportion of patients, whereas other aspects of tubular function appear to be normal. We could not find an association between renal dysfunction and the presence of the sickle cell trait.
There are some reports indicating pronounced humoral and cellular immune responses in hyperreactive onchocerciasis. 17, 33 Therefore, we hypothesized that hyperreactive patients might be prone to develop immune-mediated glomerular disorders; however, this could not be verified. Protein excretion in those with the hyperreactive form was comparable with protein excretion in patients with generalized onchocerciasis, even if these belonged to an older age group. We also could not find any evidence for kidney disorders in putative immune individuals (endemic normals); this has also been demonstrated in endemic normal individuals in areas with B. malayi filariasis. 10 Following treatment with ivermectin, we found small but significant increases in the excretion of urinary marker proteins, which indicated glomerular as well as tubular dysfunction. The most significant effect was in the excretion of total urinary proteins in patients with high microfilarial densities (Ͼ 80 mf/mg of skin). These findings indicate that ivermectin may cause a renal dysfunction leading to a selective glomerular-tubular proteinuria. We could not find any major glomerular disturbances caused by ivermectin leading to increased serum creatinine levels. This is consistent with other reports for onchocerciasis and lymphatic filariasis. 34, 35 Thus, ivermectin seems to cause only minor damage to the glomerulum and disturbances of the reabsorption of lowmolecular weight proteins in the tubulus system. These disturbances depend on the microfilarial load of the patient. Ivermectin has also been reported to induce transient proteinuria in patients with lymphatic filariasis 9 and in loiasis, 13, 14 and cause renal pathology in an animal model with Dirofilaria immitis. 36 These findings indicate that ivermectin can cause renal disturbances in patients with filariasis. However, our results show that these glomerular and tubular disturbances are minor and do not seem to be clinically relevant in patients with onchocerciasis.
